In the rapidly advancing field of AI-powered healthcare, medical institutions seek reliable solutions that enhance patient outcomes. Cortechs.ai has emerged as the leader in this domain, with 1500+ centers globally integrating its technology into their diagnostic workflows. Here are four compelling reasons behind this widespread adoption:
1. Proven Clinical Performance
Cortechs.ai’s AI solutions are built with precision in mind. NeuroQuant, the company’s flagship brain volumetry platform, delivers fast, automated, and clinically validated quantitative MRI analysis. From supporting early detection of dementia to monitoring progression in multiple sclerosis and evaluating brain tumors, Cortechs.ai tools are trusted by leading institutions for consistent, reproducible results.
2. Global Reach and Reliability
With installations in over 1500+ centers across 44 countries, Cortechs.ai’s solutions have a significant global footprint. The platform is designed for consistent performance and stability, delivering clinical-grade AI analysis with minimal maintenance or intervention – helping hospitals scale with confidence and reliability.
3. Seamless Integration into Clinical Workflows
Cortechs.ai’s tools are built to integrate effortlessly into existing radiology workflows, without the need for user interface once installed and configured. For example, NeuroQuant results can be pre-populated into structured reporting systems, reducing the need for manual data entry and minimizing the risk of transcription errors.
One of the most practical reasons physicians choose Cortechs.ai is its extensive compatibility with the most common imaging systems used in hospitals today. Cortechs.ai’s software is validated across multiple vendors and field strengths, including MR scanners at 1.2T, 1.5T, and 3.0T, and vendors such as GE, Siemens, Philips, Canon, and Fuji. It also supports PET and PET/CT systems from GE, Siemens, and Philips.
This broad compatibility and automation ensure that institutions can implement Cortechs.ai tools without costly hardware overhauls or workflow disruptions – freeing up radiologists to focus more on clinical interpretation and patient care.
4. Comprehensive AI-Powered Solutions
Cortechs.ai offers a complete portfolio of regulatory approved AI tools tailored for neuroradiology, neurology, oncology, and urology, including:
- NeuroQuant – Brain structure segmentation for neurodegenerative diseases and disorders
- NeuroQuant MS – Lesion segmentation and tracking for FLAIR White Matter Hyperintensities
- NeuroQuant Brain Tumor – Automated segmentation, longitudinal volumetric analysis, and unique tumor microstructure insights
- NeuroQuant – Automated quantification, visualization, and longitudinal tracking of brain lesions to support ARIA surveillance
- NeuroQuant PET* – PET tracer quantification and color-coded brain segmentation
- NeuroAlign CT – Automated CT alignment and subtraction maps for improved conspicuity and more accurate reads
- OnQ Prostate – Restriction Spectrum Imaging-powered prostate imaging for advanced clinical insights
*Research use only, not FDA-cleared
All of these tools can be accessed through either a secure, cloud-based or on-premise system, allowing clinicians to upload and retrieve results from virtually anywhere with internet access. Combined with optional features such as dark background reports, CSV output for big data analytics, and longitudinal tracking, these integrations allow physicians to deliver more efficient, personalized care without compromising productivity.
These tools empower physicians with quantitative data and visualizations that support faster, more informed clinical decisions across neurology, oncology, and radiology practices.
Ready to Elevate Your Diagnostic Capabilities?
Discover how Cortechs.ai’s AI-powered imaging solutions can transform your practice. With continuous product enhancements and a strong commitment to incorporating customer feedback, we’re always evolving to give clinicians what they truly need. Recent version updates to NeuroQuant are reshaping the landscape of what’s possible in neuroimaging. With exciting new developments on the horizon, there’s never been a better time to explore the future of smarter imaging insights. Book a meeting now and see why clinicians around the world continue to choose Cortechs.ai.
References
- Cortechs.ai. The Benefits and Limitations of Neuroimaging AI Software in Traditional Diagnostic Workflow. Published October 28, 2024. Accessed May 1, 2025. https://www.cortechs.ai/the-benefits-and-limitations-of-neuroimaging-ai-software-in-traditional-diagnostic-workflow
- Pena A. #ACTRIMS2020 – CorTechs Says AI Models May Improve Early MS Diagnosis. Multiple Sclerosis News Today. Published March 2, 2020. Accessed May 1, 2025. https://multiplesclerosisnewstoday.com/news-posts/2020/03/02/actrims2020-mri-based-ai-models-may-aid-in-early-ms-diagnosis-cortechs-says
- Cortechs.ai Portfolio: [Cortechs.ai Product Overview PDF, 2025 Edition]
